SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-187296
Filing Date
2022-07-01
Accepted
2022-07-01 17:06:31
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 d372672ds3.htm S-3 460456
2 EX-1.2 d372672dex12.htm EX-1.2 200178
3 EX-4.2 d372672dex42.htm EX-4.2 292340
4 EX-4.4 d372672dex44.htm EX-4.4 98159
5 EX-4.5 d372672dex45.htm EX-4.5 96499
6 EX-4.6 d372672dex46.htm EX-4.6 85372
7 EX-5.1 d372672dex51.htm EX-5.1 27977
8 EX-23.1 d372672dex231.htm EX-23.1 1668
9 EX-FILING FEES d372672dexfilingfees.htm EX-FILING FEES 46419
10 GRAPHIC g372672g0629121600093.jpg GRAPHIC 5381
11 GRAPHIC g372672g96e78.jpg GRAPHIC 8169
  Complete submission text file 0001193125-22-187296.txt   1328968
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Filer) CIK: 0001576885 (see all company filings)

IRS No.: 364108129 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-266004 | Film No.: 221062246
SIC: 2836 Biological Products, (No Diagnostic Substances)